Loading profile…
Pulling IRS BMF, Form 990 filings, peer benchmarks, programs, people, and grants.
Pulling IRS BMF, Form 990 filings, peer benchmarks, programs, people, and grants.
DBA: N/A
EIN 85-3281192 · Snapshot of IRS recognition, filing currency, financial health, and governance.
In the United States, approximately 10-20% of ovarian cancer and 6% of breast cancer diagnoses are caused by inheritable brca1 and brca2 mutations. Of those with a brca 1 or 2 mutation, there is a 17-44% risk of developing ovarian cancer and a 69-72% risk of developing breast cancer by age 80. Sadly, only 20% of eligible us women have undergone genetic testing. This severe under-utilization creates missed opportunities for early detection and prevention. Unfortunately, at this time, the healthcare system places little emphasis on prevention. Therefore, we feel it is important to empower, educate and encourage those touched by breast and ovarian cancer to take personal responsibility for their own health by seeking genetic counseling.
Principal Officer
KATHRYN Hernandez
Total Revenue
$27K
FY2023
Total Expenses
$35K
FY2023
Net Assets
$25K
Program Ratio
98.5%
expenses on programs
Employees
—
Volunteers
—
Board Members
—
Voting
—
Independent
8 answers compiled from IRS Form 990, BMF, Pub 78, and the Auto-Revocation List.